Abstract:New caffeic acid phenethyl ester (CAPE) derivatives containing quinolines or isoquinolines were synthesized and evaluated for their role in the wound‐healing process. Several compounds demonstrated a proliferative effect on HaCat and human gingival fibroblasts (HGF) cells. The most promising compounds showed favorable chemical and thermal stability improvements. Chronic wounds significantly impact the patients' quality of life, creating an urgent interdisciplinary clinical challenge. The development of novel agents capable of accelerating the healing process is essential. Caffeic acid phenethyl ester (CAPE) has demonstrated positive effects on skin regeneration. However, its susceptibility to degradation limits its pharmaceutical application. Chemical modification of the structure improves the pharmacokinetics of this bioactive phenol. Hence, two novel series of CAPE hybrids were designed, synthesized, and investigated as potential skin regenerative agents. To enhance the stability and therapeutic efficacy, a caffeic acid frame was combined with quinolines or isoquinolines by an ester (1a–f) or an amide linkage (2a–f). The effects on cell viability of human gingival fibroblasts (HGFs) and HaCaT cells were evaluated at different concentrations; they are not cytotoxic, and some proved to stimulate cell proliferation. The most promising compounds underwent a wound‐healing assay in HGFs and HaCaT at the lowest concentrations. Antimicrobial antioxidant properties were also explored. The chemical and thermal stabilities of the best compounds were assessed. In silico predictions were employed to anticipate skin penetration capabilities. Our findings highlight the therapeutic potential of caffeic acid phenethyl ester (CAPE) derivatives 1a and 1d as skin regenerative agents, being able to stimulate cell proliferation, control bacterial growth, regulate ROS levels, and being thermally and chemically stable. An interesting structure–activity relationship was discussed to suggest a promising multitargeted approach for enhanced wound healing.

The Pluripotent Activities of Caffeic Acid Phenethyl Ester

Bioactivity and Chemical Synthesis of Caffeic Acid Phenethyl Ester and Its Derivatives

Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent?

Caffeic Acid Phenethyl Ester: A Review of Its Antioxidant Activity, Protective Effects against Ischemia-reperfusion Injury and Drug Adverse Reactions

Therapeutic efficacy of Caffeic acid phenethyl ester in cancer therapy: An updated review

Antioxidant Capacity of Caffeic Acid Phenethyl Ester in Scavenging Free Radicals by a Computational Insight

Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells

Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities

Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma

Caffeic acid phenethyl ester protects against oxidative stress and dampens inflammation via heme oxygenase 1

Caffeic Acid phenethyl ester is a potential therapeutic agent for oral cancer

Antitumor activity of caffeic acid 3,4-dihydroxyphenethyl ester and its pharmacokinetic and metabolic properties

Caffeic Acid Phenethyl Ester and Its Benzoyl Derivatives: Synthesis and X-ray Structural Analysis

Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function

Potential Selective Antitumor, Antimicrobial and Antiprotozoal Agents

Caffeic Acid Phenethyl Ester Inhibits the Proliferation of HEp2 Cells by Regulating Stat3/Plk1 Pathway and Inducing S Phase Arrest.

Caffeic acid derivatives, analogs and applications: a patent review (2009 – 2013)

CAPE derivatives: Multifaceted agents for chronic wound healing

Synthesis And Biological Evaluation Of Caffeic Acid 3,4-Dihydroxyphenethyl Ester

Influence of caffeic acid phenethyl ester on bone healing in a rat model

Ethanolic Extract of Propolis and CAPE as Cardioprotective Agents against LPS and IFN-α Stressed Cardiovascular Injury